Attending AI Summit New York? Foley & Lardner LLP is a proud supporter of this gathering of innovators and invites you to stop by our booth to discuss the ways artificial intelligence is changing the way we live, work, and play.
As part of the programming, Nikhil Pradhan (Senior Counsel, Boston) will be speaking on the Industries stage during the following panel session:
How Will AI Transform Drug Discovery and What Challenges We Need To Account For? | December 6 at 12:25 p.m. – 1:05 p.m
The benefits of AI-powered drug making include increased volume and speed to market, as AI algorithms facilitate efficient analysis of biological datasets and aid in target identification, virtual screening, and drug design. However, challenges associated with AI-powered drug making are plentiful – how do we address and tackle those in a timely manner? What are industry leaders doing in this space?
- Andrew Brosnan, Principal Analyst, AI Applications in Life Sciences – Omdia
- Nikhil Pradhan, Senior Counsel – Foley & Lardner LLP
- Var Shankar, Executive Director – Responsible AI Institute
- Martin Alexander Gershon, Managing Partner and CIO, Endeavor Venture Funds & Senior Executive Investor-in-Residence Techstars NY powered by J.P. Morgan